Focal has developed innovative MR image-guidance “fusion” technology that co-registers MRI with live ultrasound to give a 3D map of suspicious lesions and tracks the location of the ultrasound probe for accurate targeting. This leads to increased detection of clinically significant cancer and better treatment options. Focal Healthcare’s lead product, Fusion Bx, utilizes fusion technology to enable targeted prostate biopsy procedures.